[1]
|
Liang, T.J., Liu, S.I., Chen, Y.C., Chang, P.M., Huang, W.C., Chang, H.T., et al. (2017) Analysis of Gallstone Disease after Gastric Cancer Surgery. Gastric Cancer, 20, 895-903. https://doi.org/10.1007/s10120-017-0698-5
|
[2]
|
Anveden, A., Peltonen, M., Naslund, I., Torgerson, J. and Carlsson, L.M.S. (2020) Long-Term Incidence of Gallstone Disease after Bariatric Surgery: Results from the Nonran-domized Controlled Swedish Obese Subjects Study. Surgery for Obesity and Related Diseases, 16, 1474-1482. https://doi.org/10.1016/j.soard.2020.05.025
|
[3]
|
Browning, K.N. and Travagli, R.A. (2014) Central Nervous System Control of Gastrointestinal Motility and Secretion and Modulation of Gastrointestinal Functions. Comprehensive Physiology, 4, 1339-1368.
https://doi.org/10.1002/cphy.c130055
|
[4]
|
Wang, C.J., Kong, S.H., Park, J.H., Choi, J.H., Park, S.H., Zhu, C.C., et al. (2021) Preservation of Hepatic Branch of the Vagus Nerve Reduces the Risk of Gallstone Formation after Gastrectomy. Gastric Cancer, 24, 232-244.
https://doi.org/10.1007/s10120-020-01106-z
|
[5]
|
Nabae, T., Yokohata, K., Otsuka, T., Inoue, K., Yamaguchi, K., Chijiiwa, K., et al. (2002) Effect of Truncal Vagotomy on Sphincter of Oddi Cyclic Motility in Conscious Dogs. Annals of Surgery, 236, 98-104.
https://doi.org/10.1097/00000658-200207000-00015
|
[6]
|
Wang, H.H., Portincasa, P. and Wang, D.Q. (2019) Update on the Molecular Mechanisms Underlying the Effect of Cholecystokinin and Cholecystokinin-1 Receptor on the Formation of Cholesterol Gallstones. Current Medicinal Chemistry, 26, 3407-3423. https://doi.org/10.2174/0929867324666170619104801
|
[7]
|
Svane, M.S., Bojsen-Moller, K.N., Martinussen, C., Dirksen, C., Madsen, J.L., Reitelseder, S., et al. (2019) Postprandial Nutrient Handling and Gastrointestinal Hormone Secretion after Roux-en-Y Gastric Bypass vs Sleeve Gastrectomy. Gastroenterology, 156, 1627-1641. https://doi.org/10.1053/j.gastro.2019.01.262
|
[8]
|
Seo, G.H., Lim, C.S. and Chai, Y.J. (2018) Incidence of Gall-stones after Gastric Resection for Gastric Cancer: A Nationwide Claims-Based Study. Annals of Surgical Treatment and Research, 95, 87-93.
|
[9]
|
Suh, Y.S., Han, D.S., Kong, S.H., Kwon, S., Shin, C.I., Kim, W.H., et al. (2014) Lap-aroscopy-Assisted Pylorus-Preserving Gastrectomy Is Better than Laparoscopy-Assisted Distal Gastrectomy for Mid-dle-Third Early Gastric Cancer. Annals of Surgery, 259, 485-493. https://doi.org/10.1097/SLA.0b013e318294d142
|
[10]
|
杜耀, 李卫平, 熊辉, 等. 保留幽门胃切除术治疗早期胃中部癌有效性和安全性的Meta分析[J]. 中华胃肠外科杂志, 2020, 23(11): 1088-1096.
|
[11]
|
Fujita, S., Kimata, M., Matsumoto, K., Sasakura, Y., Terauchi, T., Furukawa, J., et al. (2022) Important Risk Factors for Gallstones after Laparoscopic Gastrectomy: A Retrospective Study. BMC Surgery, 22, Article No. 5.
https://doi.org/10.1186/s12893-021-01458-y
|
[12]
|
Paik, K.H., Lee, J.C., Kim, H.W., Kang, J., Lee, Y.S., Hwang, J.H., et al. (2016) Risk Factors for Gallstone Formation in Resected Gastric Cancer Patients. Medicine (Baltimore), 95, e3157. https://doi.org/10.1097/MD.0000000000003157
|
[13]
|
Chen, Y. and Li, Y. (2017) Related Factors of Post-operative Gallstone Formation after Distal Gastrectomy: A Meta-Analysis. Indian Journal of Cancer, 54, 43-46. https://doi.org/10.4103/ijc.IJC_91_17
|
[14]
|
Sneineh, M.A., Harel, L., Elnasasra, A., Razin, H., Rotmensh, A., Moscovici, S., et al. (2020) Increased Incidence of Symptomatic Cholelithiasis after Bariatric Roux-en-Y Gastric Bypass and Previous Bariatric Surgery: A Single Center Experience. Obesity Surgery, 30, 846-850. https://doi.org/10.1007/s11695-019-04366-6
|
[15]
|
Golzarand, M., Toolabi, K., Parsaei, R. and Eskandari Delfan, S. (2021) Incidence of Symptomatic Cholelithiasis Following Laparoscopic Roux-en-Y Gastric Bypass Is Comparable to Laparoscopic Sleeve Gastrectomy: A Cohort Study. Digestive Diseases and Sciences. https://doi.org/10.1007/s10620-021-07306-6
|
[16]
|
Fukagawa, T., Katai, H., Saka, M., Morita, S., Sano, T. and Sasako, M. (2009) Gallstone Formation after Gastric Cancer Surgery. Journal of Gastrointestinal Surgery, 13, 886-889. https://doi.org/10.1007/s11605-009-0832-8
|
[17]
|
Akatsu, T., Yoshida, M., Kubota, T., Shimazu, M., Ueda, M., Otani, Y., et al. (2005) Gallstone Disease after Extended (D2) Lymph Node Dissection for Gastric Cancer. World Journal of Surgery, 29, 182-186.
https://doi.org/10.1007/s00268-004-7482-5
|
[18]
|
Liu, F.L., Lu, W.B. and Niu, W.X. (2010) XbaI Polymorphisms of Apolipoprotein B Gene: Another Risk Factor of Gallstone Formation after Radical Gastrectomy. World Journal of Gastroenterology, 16, 2549-2553.
https://doi.org/10.3748/wjg.v16.i20.2549
|
[19]
|
Lee, S.H., Jang, D.K., Yoo, M.W., Hwang, S.H., Ryu, S.Y., Kwon, O.K., et al. (2020) Efficacy and Safety of Ursodeoxycholic Acid for the Prevention of Gallstone Formation after Gastrectomy in Patients with Gastric Cancer: The PEGASUS-D Randomized Clinical Trial. JAMA Surgery, 155, 703-711. https://doi.org/10.1001/jamasurg.2020.1501
|
[20]
|
Della, P.A., Lange, J., Hilbert, J., Archid, R., Königsrainer, A., Quante, M., et al. (2019) Ursodeoxycholic Acid for 6 Months After Bariatric Surgery Is Impacting Gallstone Associated Morbidity in Patients with Preoperative Asymptomatic Gallstones. Obesity Surgery, 29, 1216-1221. https://doi.org/10.1007/s11695-018-03651-0
|
[21]
|
Salman, M.A., Salman, A., Mohamed, U.S., Hussein, A.M., Ameen, M.A. and Omar, H.S.E., et al. (2022) Ursodeoxycholic Acid for the Prevention of Gall Stones after Laparoscopic Sleeve Gastrectomy: A Prospective Controlled Study. Surgical Endoscopy. https://doi.org/10.1007/s00464-021-08980-3
|
[22]
|
Machado, F., Castro, F.H., Babadopulos, R., Rocha, H.A.L., Rocha, J.L.C., Moraes Filho, M.O. (2019) Ursodeoxycholic Acid in the Prevention of Gallstones in Patients Subjected to Roux-en-Y Gastric Bypass1. Acta Cirúrgica Brasileira, 34, e631258487. https://doi.org/10.1590/s0102-865020190010000009
|
[23]
|
Fearon, N.M., Kearns, E.C., Kennedy, C.A., Conneely, J.B. and Heneghan, H.M. (2022) The Impact of Ursodeoxycholic Acid on Gallstone Disease after Bariatric Surgery: A Meta-Analysis of Randomized Control Trials. Surgery for Obesity and Related Diseases, 18, 77-84. https://doi.org/10.1016/j.soard.2021.10.004
|
[24]
|
Haal, S., Guman, M., Boerlage, T., Acherman, Y.I.Z., de Brauw, L.M., Bruin, S., et al. (2021) Ursodeoxycholic Acid for the Prevention of Symptomatic Gallstone Disease after Bariatric Surgery (UPGRADE): A Multicentre, Double-Blind, Randomised, Placebo-Controlled Superiority Trial. The Lancet Gastroenterology and Hepatology, 6, 993-1001.
https://doi.org/10.1016/S2468-1253(21)00301-0
|
[25]
|
Bencini, L., Marchet, A., Alfieri, S., Rosa, F., Verlato, G., Marrelli, D., et al. (2019) The Cholegas Trial: Long-Term Results of Prophylactic Cholecystectomy during Gastrectomy for Cancer—A Randomized-Controlled Trial. Gastric Cancer, 22, 632-639. https://doi.org/10.1007/s10120-018-0879-x
|
[26]
|
Allatif, R.E.A., Mannaerts, G.H.H., Al Afari, H.S.T., Hammo, A.N., Al Blooshi, M.S., Bekdache, O.A., et al. (2021) Concomitant Cholecystectomy for Asymptomatic Gallstones in Bariatric Surgery-Safety Profile and Feasibility in a Large Tertiary Referral Bariatric Center. Obesity Surgery, 32, 295-301. https://doi.org/10.1007/s11695-021-05798-9
|
[27]
|
Lee, D.H., Park, Y.H., Kwon, O.S. and Kim, D. (2022) Laparoscopic Cholecystectomy in Patients with Previous Upper Midline Abdominal Surgery: Comparison of Laparo-scopic Cholecystectomy after Gastric Surgery and Non-Gastric Surgery Using Propensity Score Matching. Surgical Endoscopy, 36, 1424-1432.
https://doi.org/10.1007/s00464-021-08427-9
|
[28]
|
Han, C., Shan, X., Yao, L., Yan, P., Li, M., Hu, L., et al. (2018) Robotic-Assisted versus Laparoscopic Cholecystectomy for Benign Gallbladder Diseases: A Systematic Review and Meta-Analysis. Surgical Endoscopy, 32, 4377-4392.
https://doi.org/10.1007/s00464-018-6295-9
|